Biotech Values

[mcbio]

anthera...I always liked the lupus drug and thought it was a mistake to run trials on the cv Drug

I see they just had an interim look at the Phase 2b results ( http://investor.anthera.com/releasedetail.cfm?ReleaseID=654023 ) and they didn't get a halt for efficacy though trial was recommended to continue with top-line results expected in 2Q12. This is presumably a big binary event for them, given this failure and most of their other stuff looking very early stage.